SEC Form 4
Health In Tech, Inc. (HIT) insider trading
In the 12 months to Oct 26, 2026, 2 HIT insiders reported open-market sales of $39.8K across 4 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $39.8K
- 4 filings · 2 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 2 of 4
- $12.8K of $39.8K sold (32%)
Who traded HIT, and when
- Sale
- Sale, pre-arranged (10b5-1)
HIT daily close from Oct 27, 2025 to Oct 26, 2026, between $0.53 and $2.94, last $0.53. 4 sale and 0 purchase filings by 2 insiders, marked at their filing dates. Timothy Hayes, Director: sold $27.0K across 2 filings, first filed Sep 11, 2026, last Sep 15, 2026. Zain Syed Hasan, Chief Growth Officer: sold $12.8K across 2 filings, first filed Sep 14, 2026, last Oct 19, 2026.
Largest mark · tap a row for others
Timothy Hayes · Director
Filing 1 of 2 within a week · $26,965 total
Sale $16,249
17,730 shares at $0.92 avg
Filed Sep 11, 2026 · traded Sep 9
Close on filing date $0.91
Timothy Hayes · Director
Director
$27.0K soldZain Syed Hasan · Chief Growth Officer
Chief Growth Officer
$12.8K soldOpen-market trades
4 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Timothy Hayes | Director | $27.0K | — | 2 | — | |
| Zain Syed Hasan | Chief Growth Officer | $12.8K | — | 2 | 100% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Zain Syed Hasan Chief Growth Officer | SalePre-arranged (10b5-1) | 3,333 | $0.62 | $2.1K | 173,660 | |
traded | Timothy Hayes Director | Sale | 12,000 | $0.89 | $10.7K | 108,780 | |
traded | Zain Syed Hasan Chief Growth Officer | SalePre-arranged (10b5-1) | 11,667 | $0.92 | $10.7K | 188,544 | |
traded | Timothy Hayes Director | Sale | 17,730 | $0.92 | $16.2K | 120,780 |
GET /stocks/filings/vX/form-4?tickers=HIT&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"HIT"
],
"issuer_cik": "0002019505",
"owner_cik": "0002102674",
"accession_number": "0001213900-26-110783",
"form_type": "4",
"filing_date": "2026-10-19",
"period_of_report": "2026-10-15",
"issuer_name": "Health In Tech, Inc.",
"issuer_trading_symbol": "HIT",
"owner_name": "Hasan Zain Syed",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Growth Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-16",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 3333,
"transaction_price_per_share": 0.62,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 173660,
"transaction_value": 2066.46,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F3",
"description": "The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026."
},
{
"id": "F4",
"description": "The reported price in Column 4 is a weighted average price. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price underlying the weighted average price disclosed in this footnote."
}
]
},
{
"tickers": [
"HIT"
],
"issuer_cik": "0002019505",
"owner_cik": "0002020283",
"accession_number": "0001213900-26-100128",
"form_type": "4",
"filing_date": "2026-09-15",
"period_of_report": "2026-09-14",
"issuer_name": "Health In Tech, Inc.",
"issuer_trading_symbol": "HIT",
"owner_name": "Hayes Timothy",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-14",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 12000,
"transaction_price_per_share": 0.893,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 108780,
"transaction_value": 10716,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8694 to $0.943 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 39 records
- Tax withholding21 records
- Grants and awards18 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Health In Tech, Inc.'s CEO sold stock?
No. Sanjay K. Shrestha and LinLin Qian and Tim Donald Johnson (CEOs) made no open-market sales filed as CEO in the last 12 months.
How current is HIT’s insider data?
These are HIT Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track HIT insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for HIT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.